Literature DB >> 9714045

Familial aggregation of colorectal cancer in Egypt.

A S Soliman1, M L Bondy, B Levin, S El-Badawy, H Khaled, A Hablas, S Ismail, M Adly, K G Mahgoub, R S McPherson, R P Beasley.   

Abstract

We have investigated the familial aggregation of colorectal cancer and hereditary nonpolyposis colorectal cancer (HNPCC) in Egypt because of the high incidence of colorectal cancer in Egyptian children and young adults and the prevalence of consanguinity there. In a pilot study, we conducted detailed interviews with 111 Egyptian colorectal cancer patients and 111 healthy Egyptian controls about their family histories of colorectal cancer, and other cancers, consanguinity, age at diagnosis, symptoms and recurrence. Eight patients (7.2%) had one or more first- or second-degree relatives under age 40 with colorectal cancer, suggestive of HNPCC by the Amsterdam criteria. One of these families had a typical history of HNPCC, with 4 relatives having colorectal cancer in 3 generations; 3 of these relatives were younger than age 45 at colon cancer diagnosis, and other relatives had extracolonic tumors. Another 14 patients (12.6%) had a first- or second-degree relative with a family history of other neoplasms such as endometrial, urinary and hepatobiliary cancers that could also be related to HNPCC. Four patients with early-onset colon cancer and a family history of other HNPCC-related cancers reported that their parents were first-degree cousins.

Entities:  

Mesh:

Year:  1998        PMID: 9714045     DOI: 10.1002/(sici)1097-0215(19980911)77:6<811::aid-ijc1>3.0.co;2-x

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Lifestyle, occupational, and reproductive factors and risk of colorectal cancer.

Authors:  An-Chi Lo; Amr S Soliman; Hussein M Khaled; Ahmed Aboelyazid; Joel K Greenson
Journal:  Dis Colon Rectum       Date:  2010-05       Impact factor: 4.585

2.  Colorectal cancer in a population with endemic Schistosoma mansoni: is this an at-risk population?

Authors:  Khaled M Madbouly; Anthony J Senagore; Abir Mukerjee; Ahmed M Hussien; M A Shehata; Philippa Navine; Conor P Delaney; Victor W Fazio
Journal:  Int J Colorectal Dis       Date:  2006-06-20       Impact factor: 2.571

3.  Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt.

Authors:  Amr S Soliman; Nabih El-Ghawalby; Farouk Ezzat; Melissa L Bondy; Ahmed Soultan; Mohamed Abdel-Wahab; Omar Fathy; Gamal Ebidi; Nadia Bassiouni; Ahmed El-Ghawalbi; Bernard Levin; James L Abbruzzese
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registry.

Authors:  Darlene Veruttipong; Amr S Soliman; Samuel F Gilbert; Taylor S Blachley; Ahmed Hablas; Mohamed Ramadan; Laura S Rozek; Ibrahim A Seifeldin
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

5.  Family history of colorectal cancer in Iran.

Authors:  Mahboobeh Mahdavinia; Faraz Bishehsari; Reza Ansari; Nasim Norouzbeigi; Ahmad Khaleghinejad; Mahshid Hormazdi; Naser Rakhshani; Reza Malekzadeh
Journal:  BMC Cancer       Date:  2005-09-05       Impact factor: 4.430

6.  Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients.

Authors:  A S Soliman; M L Bondy; S A El-Badawy; N Mokhtar; S Eissa; S Bayoumy; I A Seifeldin; P S Houlihan; J R Lukish; T Watanabe; A O Chan; D Zhu; C I Amos; B Levin; S R Hamilton
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

7.  A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families.

Authors:  Zeinab Ghorbanoghli; Carol Jabari; Walid Sweidan; Wail Hammoudeh; George Cortas; Ala I Sharara; Amal Abedrabbo; Ijad Hourani; Bahareh Mahjoubi; Keivan Majidzadeh; Nurdan Tözün; Hadia Ziada-Bouchaar; Waseem Hamoudi; Osama Diab; Hamid Reza Khorram Khorshid; Henry Lynch; Hans Vasen
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.